<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For Quarterly Period Ended September 30, 1996 Commission File Number 0-21068
SIGHT RESOURCE CORPORATION
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 04-3181524
- --------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
67 South Bedford Street
Burlington, MA 01803
- --------------------------------------------------------------------------------
(Address of principal executive offices)
617-229-1100
- --------------------------------------------------------------------------------
(Issuer's telephone number)
N/A
- --------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since the
last report)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
for such shorter period that the issuer was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.
Yes X No
--- ---
APPLICABLE ONLY TO CORPORATE ISSUERS:
State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:
On November 8,1996, 8,643,712 shares of common stock, par value $0.01 per share,
were outstanding.
TOTAL PAGES 15
EXHIBIT INDEX AT PAGE 13
1
<PAGE> 2
SIGHT RESOURCE CORPORATION
INDEX
PART I. FINANCIAL INFORMATION PAGE
----
Item 1 Financial Statements
Consolidated Balance Sheets as of September 30, 1996, and
December 31, 1995 3
Consolidated Statements of Operations for the Three and Nine
Months Ended September 30, 1996 and 1995 4
Consolidated Statements of Cash Flows for the Nine
Months Ended September 30, 1996 and 1995 5
Notes to Consolidated Financial Statements 6
Item 2 Management's Discussion and Analysis of Financial Condition
and Results of Operations 10
PART II. OTHER INFORMATION
Item 6 Exhibits and Reports on Form 8-K 13
Signatures 14
2
<PAGE> 3
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
SIGHT RESOURCE CORPORATION
<TABLE>
Consolidated Balance Sheets
(In thousands,except share and per share data)
<CAPTION>
September 30, December 31,
1996 1995
-------- --------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 11,519 $ 8,035
Accounts receivable, net of allowance
of $338 and $277, respectively 1,445 662
Inventories 2,612 1,560
Prepaid expenses and other current assets 461 171
-------- --------
Total current assets 16,037 10,428
-------- --------
Property and equipment 14,044 8,258
Less accumulated depreciation (6,910) (2,480)
-------- --------
Net property and equipment 7,134 5,778
-------- --------
Other assets:
Intangible assets 12,303 6,908
Other assets 202 135
-------- --------
Total other assets 12,505 7,043
-------- --------
$ 35,676 $ 23,249
======== ========
LIABILITIES & STOCKHOLDERS' EQUITY
Current liabilities:
Revolving note payable $ 475 $ 475
Current portion of long term debt 800 400
Accounts payable 2,621 1,727
Accrued expenses 2,952 2,499
-------- --------
Total current liabilities 6,848 5,101
-------- --------
Non-current liabilities:
Long term debt, less current maturities 1,700 1,000
Other liabilities 354 703
-------- --------
Non-current liabilities 2,054 1,703
-------- --------
Commitments and contingencies -- --
Stockholders' equity:
Preferred Stock, $.01 par value. Authorized 5,000,000
shares; no shares issued and outstanding -- --
Common Stock, $.01 par value. Authorized 20,000,000
shares; issued and outstanding 8,643,712 and 6,346,615
shares at September 30, 1996 and December 31, 1995,
respectively 86 63
Additional paid-in capital 37,607 25,794
Shares issuable 432 --
Accumulated deficit (11,351) (9,412)
-------- --------
Total stockholders' equity 26,774 16,445
-------- --------
$ 35,676 $ 23,249
======== ========
</TABLE>
See accompanying notes to consolidated financial statements.
3
<PAGE> 4
SIGHT RESOURCE CORPORATION
<TABLE>
Consolidated Statements of Operations
(In thousands, except per share data)
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30, September 30, September 30,
1996 1995 1996 1995
------------------------------------------------------------------
<S> <C> <C> <C> <C>
Net revenue $9,764 $ 5,202 $21,342 $13,566
Cost of revenue 3,787 2,352 8,331 6,497
------ ------- ------- -------
Gross profit 5,977 2,850 13,011 7,069
Selling, general and administrative expenses 6,702 3,991 15,148 10,593
------ ------- ------- -------
Loss from operations (725) (1,141) (2,137) (3,524)
------ ------- ------- -------
Other income (expense)
Interest income 169 70 349 280
Interest expense (38) (72) (151) (179)
------ ------- ------- -------
Total other income (expense) 131 (2) 198 101
------ ------- ------- -------
Net loss $ (594) $(1,143) $(1,939) $(3,423)
====== ======= ======= =======
Net loss per common share $(0.07) $ (0.21) $ (0.28) $ (0.66)
====== ======= ======= =======
Weighted average number of common
shares outstanding 8,158 5,374 6,988 5,171
====== ======= ======= =======
</TABLE>
See accompanying notes to consolidated financial statements.
4
<PAGE> 5
SIGHT RESOURCE CORPROATION
<TABLE>
Consolidated Statements of Cash Flows
(In thousands)
Nine Months Ended
September 30,1996 September 30,1995
----------------- -----------------
<S> <C> <C>
Operating activities:
Net loss $(1,939) $(3,423)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization 1,497 1,202
Changes in operating assets and liabilities:
Accounts receivable (358) (110)
Inventories 30 419
Prepaid expenses and other current assets (222) 43
Accounts payable and accrued expenses (1,185) (655)
------- -------
Net cash used in operating activities (2,177) (2,524)
------- -------
Investing activities:
Purchases of property and equipment (767) (1,693)
Acquisition of subsidiaries (2,854) (2,363)
Other assets (4) 44
------- -------
Net cash used in investing activities (3,625) (4,012)
------- -------
Financing activities:
Principal payments on long term debt (300) (300)
Other liabilities (349) --
Net proceeds from exercise of warrants -- 1,509
Net proceeds from issuance of common stock 9,935 --
------- -------
Net cash provided by financing 9,286 1,209
activities
------- -------
Effect of exchange rate changes on cash -- 19
------- -------
Net increase (decrease) in cash and cash equivalents 3,484 (5,308)
Cash and cash equivalents, beginning of period 8,035 10,194
------- -------
Cash and cash equivalents, end of period $11,519 $ 4,886
======= =======
Supplemental Disclosure:
Interest paid $ 158 $ 150
======= =======
Non-cash financing activities:
Issuance of stock for equipment -- $ 128
======= =======
Aquisitions:
Assets acquired $10,266 $ 7,696
Net liabilities assumed (2,533) (3,310)
Notes payable (1,400) --
Common stock issued (1,901) (1,727)
Common stock issuable (432) --
------- -------
Cash paid 4,000 2,659
Less cash acquired (1,146) (296)
------- -------
Net cash paid for acquisition $ 2,854 $ 2,363
======= =======
</TABLE>
See accompanying notes to consolidated financial statements.
5
<PAGE> 6
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
(1) THE COMPANY
(a) Nature of Business
The business of Sight Resource Corporation is to participate in the
delivery of a complete range of eye care products and services through
integrated networks of opticians, optometrists and ophthalmologists.
Effective October 31, 1995, the Company changed its name to Sight
Resource Corporation from NewVision Technology, Inc. to better reflect
its expanded corporate mission.
(b) US Acquisitions
Effective January 1, 1995, the Company purchased substantially all the
assets of Cambridge Eye Associates, Inc. ("Cambridge Eye") for $1,690 in
cash, 424,000 shares of common stock and the assumption of approximately
$1,600 of net liabilities. The transaction was accounted for using the
purchase method of accounting. Cambridge Eye operates 22 eye care centers
throughout New England which provide comprehensive vision care products
and services to residents of this region.
Effective July 1, 1995, the Company purchased certain assets and
liabilities of Douglas Vision World, Inc. ("Vision World") for
approximately $970 in cash, 131,525 shares of common stock, $660 payable
over a 3 year period and $250 payable over 18 months. The transaction was
accounted for using the purchase method of accounting. Vision World
operates eight eye care centers located throughout Rhode Island which
provide comprehensive vision care services to residents of this state.
Effective July 1, 1996, the Company purchased certain assets and assumed
certain liabilities of The E.B. Brown Optical Company and Brown Optical
Laboratories, Inc. as well as entered into a merger with E.B. Brown
Opticians, Inc. (together "EB Brown") for approximately $4,000 in cash,
521,997 shares of common stock issued, 71,181 shares of common stock to
be issued and $1,400 in notes payable over an eighteen month period. The
transaction was accounted for using the purchase method of accounting. EB
Brown operates forty-two eye care centers located throughout Ohio and
Western Pennsylvania which provide optometric and audiology goods and
services to persons with vision and hearing disorders.
The results of operations of the above acquisitions have been included in
the consolidated financial statements from their respective dates of
acquisition. The excess of the purchase price and expenses associated
with each acquisition over the estimated fair value of the net assets
acquired has been recorded as goodwill. Included in intangible assets is
approximately $5,761 of purchase price and expenses over book value of
net assets acquired associated with the acquisition of EB Brown for which
the fair value is currently being assessed by an independent appraiser.
(c) UK Operations
While the Company's initial efforts focused on building a laser vision
correction delivery model in the UK, the Company is now fully
concentrating its attention and resources on the growth opportunities in
the United States. As a result, the Company fully discontinued its
6
<PAGE> 7
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
UK operations in the fourth quarter of 1995. Excimer lasers systems used
in the UK have been or are in the process of being retrofitted and
relocated to the US.
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(a) Basis of Presentation
The accompanying consolidated financial statements have been prepared by
the Company without audit, pursuant to the rules and regulations of the
Securities and Exchange Commission. In the opinion of the Company, these
consolidated financial statements contain all adjustments (consisting of
only normal, recurring adjustments) necessary to present fairly the
financial position of Sight Resource Corporation as of September 30, 1996
and the results of its operations and cash flows for the three and nine
months ended September 30, 1996 and 1995.
The accompanying consolidated financial statements and related notes
should be read in conjunction with the audited consolidated financial
statements which are contained in the Company's Annual Report on Form
10-K for the year ended December 31, 1995.
(b) Principles of Consolidation
The accompanying consolidated financial statements include the accounts
of the Company, its wholly-owned subsidiaries and entities in which the
Company's subsidiaries assume the financial risks and rewards of such
entities through a management contract. The Company has no direct equity
ownership in these entities. All significant intercompany balances and
transactions have been eliminated.
(c) Revenue Recognition
Under existing revenue sharing arrangements for refractive surgery where
the Company is not responsible for patient billing, the Company receives
a specified payment from the medical provider for each refractive
surgical procedure performed. Accordingly, the Company recognizes revenue
on a per procedure basis at the time procedures are performed. Under
existing revenue-sharing arrangements for refractive surgery where the
Company is responsible for the collection from the patient and payment to
the ophthalmologist and other operating costs, the total patient charge
is recorded as revenue with the corresponding expenses recorded in cost
of revenue.
Revenue and the related costs from the sale of eyewear and hearing aids
are recognized at the time an order is placed. Revenue is reported net of
contractual allowances.
(d) Inventories
Inventories primarily consist of the costs of eyeglass frames, contact
lenses, ophthalmic lenses, sunglasses, industrial eyewear, hearing aids
and other optical and audiology products and are valued at the lower of
cost (using the first-in, first-out method) or market.
7
<PAGE> 8
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
(e) Property and Equipment
Property and equipment is stated at cost. The Company provides for
depreciation at the time the property and equipment is placed in service.
The straight-line method is used over the estimated useful life of the
assets.
(f) Intangible Assets
Intangible assets resulting from business acquisitions consist of
customer lists, trademarks, and the excess cost of the acquisition over
the fair value of the net assets acquired (goodwill). Certain values
assigned are based upon independent appraisals and are amortized on a
straight line basis over a period of eleven to twenty-five years. The
Company assesses the recoverability of unamortized intangible assets on
an ongoing basis by comparing anticipated operating profits and future
cash flows to net book value.
(g) Net Loss Per Share
Net loss per share of common stock is based on the weighted average
number of common shares outstanding. Common stock equivalents are not
included in the calculation because they are antidilutive.
(h) Reclassifications
Certain reclassifications were made to the 1995 Consolidated Financial
Statements to conform to the 1996 presentation.
(3) LONG TERM DEBT
<TABLE>
Long term debt is as follows:
<CAPTION>
SEPTEMBER 30, DECEMBER 31,
1996 1995
------------- ------------
<S> <C> <C>
Bank term loan, 8.906% interest rate at September 30, 1996, repayable
in quarterly installments of $100 through March
1998, followed by 4 quarterly installments of $125;
secured by all assets of one of the Company's subsidiaries $1,100 1,400
Notes payable, 7% interest rate, $400 due on September 18, 1997 and
$1,000 due on March 18, 1998; due on demand
if the Company's cash balance is less than $2,800 1,400 0
------ ------
2,500 1,400
Less current maturities 800 400
------ ------
Long term debt, less current maturities $1,700 $1,000
====== ======
</TABLE>
8
<PAGE> 9
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
The Company also has available a revolving credit facility based on
eligible accounts receivable and inventory balances which bears interest
at the bank's base rate plus 1.5% (9.75 % at September 30, 1996).
(4) STOCKHOLDERS' EQUITY
In 1996, the Company issued 1,775,000 shares of common stock for net
proceeds of approximately $9.9 million. The Company anticipates using the
net proceeds for working capital and other general corporate purposes,
including acquisitions.
9
<PAGE> 10
PART I:
ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF
1995
Statements contained in this document which are not historical fact are
forward-looking statements based upon management's current expectations that are
subject to risks and uncertainties that could cause actual results to differ
materially from those set forth in or implied by forward-looking statements.
These risks are described in the Company's Form 10K for the fiscal year ended
December 31, 1995 filed with the Securities and Exchange Commission.
OVERVIEW
The Company provides a complete range of eye care products and services
through integrated networks of opticians, optometrists and ophthalmologists. The
Company was formed in November 1992 with an initial mission of providing laser
vision correction ("LVC") as an alternative to conventional vision correction.
Together with a private health care provider in the United Kingdom, the Company
established a network of LVC centers in England and Wales which, utilizing the
Company's excimer laser systems, offered LVC to persons with nearsightedness.
While the Company's initial efforts focused on building a LVC delivery model in
the United Kingdom, the Company is now fully concentrating its attention and
resources on developing an integrated eye care delivery system to consumers and
third party payors in the Unites States
In October 1995, the FDA first approved the use of one manufacturer's
excimer laser for the treatment in the United States of nearsightedness using
LVC. In March 1996, the FDA approved a second manufacturer's excimer laser for
the same treatment. The Company had commenced consolidation of its United
Kingdom operations during the third quarter of fiscal 1995, and, following the
FDA's initial approval, had fully discontinued these operations by the fourth
quarter of fiscal 1995.
The discontinuation of its United Kingdom operations permitted the
Company to concentrate its efforts and resources on growth opportunities now
available in the United States. For this purpose, excimer laser systems
previously used in the United Kingdom have been or are being retrofitted and
relocated to the United States. As of September 30, 1996, ten laser systems were
in place in the United States.
During fiscal 1995 and 1996, the Company acquired two New England-based
and one Mid-Western-based chain of eye care centers. The first, Cambridge Eye
(MA), operates 22 eye care centers; the second, Vision World (RI), operates
eight eye care centers; and the third, EB Brown (OH) operates forty-two eye care
centers. While the Company's eye care centers continue to provide traditional
eyewear and eye care services, they now also offer patients convenient access to
LVC information and pre- and post-operative LVC services.
Cambridge Eye was acquired effective January 1, 1995. The transaction
consisted of the purchase of substantially all of the assets of Cambridge Eye,
including accounts receivable, inventory and property and equipment, for a
purchase price of $1.7 million in cash, 424,000 shares of Common Stock and the
assumption of net liabilities of approximately $1.6 million. Vision World was
acquired effective July 1, 1995. The transaction consisted of the purchase of
substantially all of the assets of Vision World, including accounts receivable,
inventory and property and equipment, for a purchase price of approximately
$970,000 in cash, 131,525 shares of Common Stock, $660,000 in cash payable over
a three-year period and $250,000 in cash payable over eighteen months. EB Brown
was acquired effective July 1, 1996. The transaction consisted of the purchase
of substantially all of the assets of EB Brown, including accounts receivable,
inventory and property and equipment, for a purchase price of approximately
$4,000,000 in cash, 521,997 shares of Common Stock, and $1,400,000 in notes
payable over eighteen months. All three acquisitions were accounted for using
the purchase method of accounting.
10
<PAGE> 11
RESULTS OF OPERATIONS
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 1996 AND 1995
NET REVENUE. The Company generated net revenue of approximately $9.8 million and
$21.3 million during the three and nine months ended September 30, 1996,
respectively, from the operation of its 72 eye care centers and ten laser vision
correction centers in the United States as compared to net revenue of
approximately $5.2 million and $13.6 million from its 29 eye care centers and
its network of laser vision correction centers in the United Kingdom for the
same periods in 1995. Of the $4.6 million, or 87.7%, increase in net revenue for
the three months ended September 30, 1996 as compared to the three months ended
September 30, 1995, approximately $3.9 million relates to the additional
forty-two eye care centers acquired effective July 1, 1996. The $7.7 million
increase in net revenue for the nine months ended September 30, 1996 as compared
to the nine months ended September 30, 1995, is primarily due to the acquisition
of EB Brown on July 1,1996 and nine months of revenue from the Vision World
acquisition in 1996 as compared to three months in 1995.
COST OF REVENUE. Cost of revenue decreased as a percent of net revenue from
45.2% ($2.4 million) and 47.9% ($6.5 million) for the three and nine months
ended September 30, 1995, respectively, to 38.8% ($3.8 million) and 39.0% ($8.3
million) for the three and nine months ended September 30, 1996, respectively.
The decrease as a percentage of net revenue is attributable to an increase in
laser vision correction procedures as well as manufacturing efficiencies
realized at the Company's central lab. Cost of revenue for the three and nine
months ended September 30, 1996 and 1995 principally consisted of (i) the cost
of manufacturing, purchasing and distributing optical products to its customers
and (ii) the cost of delivering LVC, including depreciation and maintenance on
excimer lasers.
SELLING, GENERAL AND ADMINISTRATION EXPENSES. Selling, general and
administration expenses were approximately $6.7 million and $15.1 million for
the three and nine months ended September 30, 1996, respectively, as compared to
$4.0 million and $10.6 million for the three and nine months ended September 30,
1995, respectively. The increase primarily relates to payroll and facility costs
incurred in operating additional eye care centers in the first three quarters of
fiscal 1996 as compared to the first three quarters in fiscal 1995. Selling,
general and administrative expenses, as a percentage of net revenue, declined
from 76.7% and 78.1% for the three and nine months ended September 30, 1995,
respectively, to 68.6% and 71.0% for the three and nine months ended September
30, 1996, respectively. This decrease is a result of operating efficiencies
which the Company began to realize from the acquisition and expansion of
multi-site eye care centers and an increase in LVC revenue.
OTHER INCOME AND EXPENSES. Interest income totaled $169,000 and $349,000 for the
three and nine months ended September 30, 1996, respectively as compared to
$70,000 and $280,000 for the three and nine months ended September 30, 1995,
respectively. This increase resulted from the investment of a higher average
cash balance during the first three quarters of fiscal 1996 as compared to the
same period in fiscal 1995. Interest expense remained comparable at
approximately $38,000 and $151,000 for the three and nine months ended September
30, 1996, respectively, as compared to $72,000 and $179,000 for the three and
nine months ended September 30, 1995, respectively.
NET LOSS. The Company realized a net loss of $594,000 ($0.07 per share) and $1.9
million ($0.28 per share) for the three and nine months ended September 30,
1996, respectively, as compared to $1.1 million ($0.21) and $3.4 million ($0.66
per share) for the three and nine months ended September 30, 1995, respectively.
The reduction in net loss is primarily attributable to the additional forty-two
eye care centers acquired during the third quarter of 1996 and eight eye care
centers acquired in the second half of fiscal year 1995.
11
<PAGE> 12
LIQUIDITY AND CAPITAL RESOURCES
At September 30, 1996, the Company had approximately $11.5 million in
cash and cash equivalents and working capital of approximately $9.2 million in
comparison to approximately $8.0 million in cash and working capital of
approximately $5.3 million as of December 31, 1995.
In 1996, the Company issued 1,775,000 shares of common stock for net
proceeds of approximately $9.9 million. The Company anticipates using the net
proceeds for working capital and other general corporate purposes, including
acquisitions.
Acquiring multi-site eye care centers is a key component of the Company's
business strategy. By acquiring multi-site eye care centers, the Company gains
critical mass of locations ensuring that potential patients and third party
payors will have convenient access to a wider variety of eye care services. It
also allows the Company to deliver these services at considerable savings by
using existing corporate and operational infrastructure, which includes store
operations, MIS, manufacturing, purchasing, distribution and training. The
Company is currently evaluating potential acquisition candidates.
<TABLE>
The Company has securities outstanding which provide it with potential
sources of financing as outlined below:
<CAPTION>
SECURITIES POTENTIAL PROCEEDS
----------------------------------------------------- ------------------
<S> <C> <C>
Warrants 2,472,100 $14,800,000
Class A Warrants 85,000 500,000
Unit Purchase Option 215,000 3,700,000
IPO Representative Warrants 85,000 1,300,000
Representative Warrants 170,000 1,478,000
-----------
$21,778,000
===========
</TABLE>
There can be no assurance that the Company will obtain any such proceeds
from the exercise of the above securities.
The Company anticipates that its working capital, cash flow from
operations, revenues from operations and interest income from cash investments,
will be adequate to fund the Company's currently proposed activities for at
least the next eighteen months. Without the exercise of a significant number of
the outstanding securities, additional financing may be needed after this
eighteen month period. The Company anticipates using financing vehicles such as
bank debt, leasing, and other sources of funding, such as additional equity
offerings, to fund its operations. There can be no assurance that the Company
will be successful in obtaining funds from any such sources. If additional funds
are raised by issuing equity securities, further dilution to the Company's
stockholders may result. If additional funds are not available, the Company may
be required to delay execution of its business plan.
The Company has approximately $11.1 million in net operating loss
carryforwards for both federal and state tax purposes at September 30, 1996
which expire through 2011 and 2001, respectively.
12
<PAGE> 13
PART II. OTHER INFORMATION
Item 6 EXHIBITS AND REPORTS ON FORM 8-K
On October 3, 1996, the Company filed a Form 8-K with respect to its
acquisition of EB Brown. The Company will file a Form 8-KA inclusive
of the required financial statements and pro-forma financial
information within sixty days of the October 3, 1996 date.
13
<PAGE> 14
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Sight Resource Corporation
Date: November 11, 1996 /S/ WILLIAM G. MCLENDON
----------------- -----------------------
William G. McLendon
Chief Executive Officer and President
(principal executive officer)
Date: November 11, 1996 /S/ ALAN MACDONALD
----------------- -------------------
Alan MacDonald
Vice President, Finance and
Administration (principal financial
and chief accounting officer)
14
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS AS OF AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10Q FOR THE QUARTERLY PERIOD
ENDED SEPTEMBER 30, 1996.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> SEP-30-1996
<EXCHANGE-RATE> 1
<CASH> 11,519
<SECURITIES> 0
<RECEIVABLES> 1,445
<ALLOWANCES> 338
<INVENTORY> 2,612
<CURRENT-ASSETS> 16,037
<PP&E> 14,044
<DEPRECIATION> 6,910
<TOTAL-ASSETS> 35,676
<CURRENT-LIABILITIES> 6,848
<BONDS> 0
<COMMON> 86
0
0
<OTHER-SE> 26,688
<TOTAL-LIABILITY-AND-EQUITY> 35,676
<SALES> 21,342
<TOTAL-REVENUES> 21,342
<CGS> 8,331
<TOTAL-COSTS> 8,331
<OTHER-EXPENSES> 15,148
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 151
<INCOME-PRETAX> (1,939)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,939)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,939)
<EPS-PRIMARY> (.28)
<EPS-DILUTED> (.28)
</TABLE>
